These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 28152540

  • 1. Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Ghouti-Terki L, Chasseuil E, Rabot N, Paintaud G, François M, Birmelé B, Darrouzain F, Büchler M, Halimi JM, Ternant D.
    Nephron; 2017; 135(4):261-267. PubMed ID: 28152540
    [Abstract] [Full Text] [Related]

  • 2. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA, Ariano RE, McCrae ML, Vercaigne LM.
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA.
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [Abstract] [Full Text] [Related]

  • 4. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis.
    Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA.
    Am J Kidney Dis; 2005 Oct; 46(4):681-7. PubMed ID: 16183423
    [Abstract] [Full Text] [Related]

  • 5. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F, Uehlinger DE.
    Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration.
    Mason NA, Neudeck BL, Welage LS, Patel JA, Swartz RD.
    Clin Nephrol; 2003 Aug; 60(2):96-104. PubMed ID: 12940611
    [Abstract] [Full Text] [Related]

  • 7. Use of vancomycin in high-flux hemodialysis: experience with 130 courses of therapy.
    Barth RH, DeVincenzo N.
    Kidney Int; 1996 Sep; 50(3):929-36. PubMed ID: 8872968
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a vancomycin dosing regimen for patients on high flux hemodialysis: an observational study.
    Soto Guerrero Y, Hernández Castillo R, Santiago E, Ramírez Yuch N, Jaume Anselmi F, Jové R, Flores R, Lebrón R, Ramírez Rivera J.
    Bol Asoc Med P R; 2012 Sep; 104(3):10-4. PubMed ID: 23156886
    [Abstract] [Full Text] [Related]

  • 9. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A, Guglielmo BJ, Hersh AL.
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [Abstract] [Full Text] [Related]

  • 10. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS, Chong YP, Noh YH, Jung JA, Kim YS.
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [Abstract] [Full Text] [Related]

  • 11. Effects of dialysis membrane on intradialytic vancomycin administration.
    Scott MK, Macias WL, Kraus MA, Clark WR, Carfagna MA, Mueller BA.
    Pharmacotherapy; 1997 Apr; 17(2):256-62. PubMed ID: 9085316
    [Abstract] [Full Text] [Related]

  • 12. Once-weekly vancomycin for patients receiving high-flux hemodialysis.
    Crawford BS, Largen RF, Walton T, Doran JJ.
    Am J Health Syst Pharm; 2008 Jul 01; 65(13):1248-53. PubMed ID: 18574015
    [Abstract] [Full Text] [Related]

  • 13. Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis.
    Decker BS, Kays MB, Chambers M, Kraus MA, Moe SM, Sowinski KM.
    Clin J Am Soc Nephrol; 2010 Nov 01; 5(11):1981-7. PubMed ID: 20616157
    [Abstract] [Full Text] [Related]

  • 14. Optimization of therapeutic drug monitoring of vancomycin in patients with chronic hemodialysis
.
    Mahmoud LB, Chaabouni Y, Ghozzi H, Feriani H, Hakim A, Kharrat M, Marrakchi C, Sahnoun Z, Jmaa MB, Zeghal K, Hachicha J.
    Clin Nephrol; 2017 Oct 01; 88(10):198-204. PubMed ID: 28793955
    [Abstract] [Full Text] [Related]

  • 15. Vancomycin hemodialysis: Clearance differences between high-flux hemodialysis and on-line hemodiafiltration.
    Rodríguez N, Gómez M, Rico N, María Campistol J, Maduell F.
    Artif Organs; 2019 Mar 01; 43(3):261-269. PubMed ID: 30302764
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
    Rider TR, Silinskie KM, Hite MS, Bress J.
    Pharmacotherapy; 2020 Oct 01; 40(10):1036-1041. PubMed ID: 32866291
    [Abstract] [Full Text] [Related]

  • 17. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
    Lewis SJ, Mueller BA.
    J Clin Pharmacol; 2021 Feb 01; 61(2):211-223. PubMed ID: 32851685
    [Abstract] [Full Text] [Related]

  • 18. [Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease].
    Pondel J, Krajewski P, Królikowska N, Tobiasz A, Augustyniak-Bartosik H, Hurkacz M.
    Pol Merkur Lekarski; 2017 Apr 21; 42(250):145-150. PubMed ID: 28530212
    [Abstract] [Full Text] [Related]

  • 19. A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear).
    Allawati H, Dallas L, Nair S, Palmer J, Thaikandy S, Hutchison C.
    Toxins (Basel); 2020 May 12; 12(5):. PubMed ID: 32408589
    [Abstract] [Full Text] [Related]

  • 20. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients.
    Denetclaw TH, Dowling TC, Steinke D.
    Ann Pharmacother; 2013 Dec 12; 47(12):1611-7. PubMed ID: 24259632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.